Private drug plans in Canada : high-cost drugs and beneficiaries, 2005 to 2017 = Régimes privés d'assurance-médicaments au Canada : médicaments et bénéficiaires à coût élevé, 2005 à 2017. : H82-35/2018-PDF
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.872255&sl=0
| Department/Agency | Canada. Patented Medicine Prices Review Board. |
|---|---|
| Title | Private drug plans in Canada : high-cost drugs and beneficiaries, 2005 to 2017 = Régimes privés d'assurance-médicaments au Canada : médicaments et bénéficiaires à coût élevé, 2005 à 2017. |
| Variant title | Régimes privés d'assurance-médicaments au Canada : médicaments et bénéficiaires à coût élevé, 2005 à 2017 |
| Publication type | Monograph |
| Language | Bilingual-[English | French] |
| Format | Electronic |
| Electronic document | |
| Note(s) | "NPDUIS. National Prescription Drug Utilization Information System. Supporting health care decision making in Canada." Includes bibliographical references. Issued also in HTML format. Text in English and in French. |
| Publishing information | [Ottawa] : Patented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, [2018] |
| Description | 1 online resource (1 page) : coloured graphs |
| Catalogue number |
|
| Subject terms | Prescription drugs Health insurance |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.- Date modified: